NOMAD POWER SOLUTIONS, INC. Deferred Compensation Arrangement with Individual, Compensation Expense
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for the quarter ending 2026-06-30 was -$219.00K.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for the quarter ending 2026-03-31 was $230.00K, a 24.09% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for the quarter ending 2025-12-31 was -$171.00K.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for the quarter ending 2025-09-30 was $310.00K.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for fiscal 2025 was $230.00K, a 38.67% decline from fiscal 2024.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for fiscal 2024 was $375.00K, a 44.03% decline from fiscal 2023.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for fiscal 2023 was $670.00K, a 24.04% decline from fiscal 2022.
- NOMAD POWER SOLUTIONS, INC. deferred compensation arrangement with individual, compensation expense for fiscal 2022 was $882.00K, a 57.94% decline from fiscal 2021.
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 3 month | Deferred Compensation Arrangement with Individual, Compensation Expense 6 month | Deferred Compensation Arrangement with Individual, Compensation Expense 9 month | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $11.00K 10-Q · filed 2026-08-14 | -$160.00K derived: sum of 3 quarters · filed 2026-08-14 | $150.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $230.00K 10-Q · filed 2026-05-14 | $59.00K derived: sum of 2 quarters · filed 2026-05-14 | $369.00K derived: sum of 3 quarters · filed 2026-05-14 | $157.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $139.00K derived: sum of 2 quarters · filed 2026-03-31 | -$73.00K derived: sum of 3 quarters · filed 2026-03-31 | $230.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $98.00K derived: sum of 2 quarters · filed 2025-11-12 | $401.00K 10-Q · filed 2025-11-12 | $309.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | -$212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $91.00K 10-Q · filed 2025-08-07 | -$1.00K derived: sum of 3 quarters · filed 2025-08-07 | -$72.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $303.00K 10-Q · filed 2025-05-12 | $211.00K derived: sum of 2 quarters · filed 2025-05-12 | $140.00K derived: sum of 3 quarters · filed 2025-05-12 | $111.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$163.00K derived: sum of 2 quarters · filed 2025-03-24 | -$192.00K derived: sum of 3 quarters · filed 2025-03-24 | $375.00K 10-K · filed 2025-03-24 |
| 2024-09-30 | -$71.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$100.00K derived: sum of 2 quarters · filed 2024-11-12 | $467.00K 10-Q · filed 2024-11-12 | $329.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $538.00K 10-Q · filed 2024-08-08 | $400.00K derived: sum of 3 quarters · filed 2024-08-08 | $691.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $567.00K 10-Q · filed 2024-05-09 | $429.00K derived: sum of 2 quarters · filed 2024-05-09 | $720.00K derived: sum of 3 quarters · filed 2024-05-09 | $632.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $153.00K derived: sum of 2 quarters · filed 2024-03-19 | $65.00K derived: sum of 3 quarters · filed 2024-03-19 | $670.00K 10-K · filed 2024-03-19 |
| 2023-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $203.00K derived: sum of 2 quarters · filed 2023-11-09 | $808.00K 10-Q · filed 2023-11-09 | $279.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $517.00K 10-Q · filed 2023-08-09 | -$12.00K derived: sum of 3 quarters · filed 2023-08-09 | -$409.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | $605.00K 10-Q · filed 2023-05-10 | $76.00K derived: sum of 2 quarters · filed 2023-05-10 | -$321.00K derived: sum of 3 quarters · filed 2023-05-10 | -$270.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | -$529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$926.00K derived: sum of 2 quarters · filed 2023-03-29 | -$875.00K derived: sum of 3 quarters · filed 2023-03-29 | $882.00K 10-K · filed 2023-03-29 |
| 2022-09-30 | -$397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$346.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.41M 10-Q · filed 2022-11-08 | $1.06M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.81M 10-Q · filed 2022-08-10 | $1.46M derived: sum of 3 quarters · filed 2022-08-10 | $1.11M derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | $1.76M 10-Q · filed 2022-05-11 | $1.41M derived: sum of 2 quarters · filed 2022-05-11 | $1.06M derived: sum of 3 quarters · filed 2022-05-11 | $3.04M derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | -$347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$694.00K derived: sum of 2 quarters · filed 2022-03-21 | $1.29M derived: sum of 3 quarters · filed 2022-03-21 | $2.10M 10-K · filed 2022-03-21 |
| 2021-09-30 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.63M derived: sum of 2 quarters · filed 2021-11-10 | $2.44M 10-Q · filed 2021-11-10 | $2.36M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.79M 10-Q · filed 2021-08-10 | $2.71M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | $810.00K 10-Q · filed 2021-05-12 | $724.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2020-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $894.00K 10-K · filed 2021-03-26 | ||
| 2020-09-30 | $980.00K 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.00K 10-Q · filed 2019-08-06 | -$8.00K derived: sum of 3 quarters · filed 2019-08-06 | |
| 2019-03-31 | $18.00K 10-Q · filed 2019-05-09 | $5.00K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2018-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $31.00K 10-K · filed 2019-03-25 | ||
| 2018-09-30 | $44.00K 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | -$25.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $6.16K 10-Q · filed 2017-08-04 | -$26.27K derived: sum of 3 quarters · filed 2017-08-04 | -$63.27K derived: sum of 4 quarters · filed 2017-08-04 |
| 2017-03-31 | $31.52K 10-Q · filed 2017-05-10 | -$907.00 derived: sum of 2 quarters · filed 2017-05-10 | -$37.91K derived: sum of 3 quarters · filed 2017-05-10 | -$13.91K derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | -$32.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$69.43K derived: sum of 2 quarters · filed 2017-03-29 | -$45.43K derived: sum of 3 quarters · filed 2017-03-29 | $28.57K 10-K · filed 2017-03-29 |
| 2016-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$13.00K derived: sum of 2 quarters · filed 2016-11-04 | $61.00K 10-Q · filed 2016-11-04 | $166.00K derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $98.00K 10-Q · filed 2016-08-10 | $203.00K derived: sum of 3 quarters · filed 2016-08-10 | $342.00K derived: sum of 4 quarters · filed 2016-08-10 |
| 2016-03-31 | $74.00K 10-Q · filed 2016-05-06 | $179.00K derived: sum of 2 quarters · filed 2016-05-06 | $318.00K derived: sum of 3 quarters · filed 2016-05-06 | $310.00K derived: sum of 4 quarters · filed 2016-05-06 |
| 2015-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $244.00K derived: sum of 2 quarters · filed 2016-03-28 | $236.00K derived: sum of 3 quarters · filed 2016-03-28 | $264.00K 10-K · filed 2016-03-28 |
| 2015-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $131.00K derived: sum of 2 quarters · filed 2015-11-10 | $159.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $20.00K 10-Q · filed 2015-08-07 | ||
| 2015-03-31 | $28.00K 10-Q · filed 2015-05-13 | |||
| 2014-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$259.00K derived: sum of 2 quarters · filed 2014-11-12 | $102.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $166.00K 10-Q · filed 2014-08-08 | ||
| 2014-03-31 | $361.00K 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |